west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "mouse model" 2 results
  • Summary and comparison of mouse models in the basic research in colorectal cancer

    ObjectiveTo summarize the common mouse models and the latest research progress in the basic research of colorectal cancer, introducing advantages, disadvantages and applications of these various models, provide references for the researchers in the selection of mouse models for their experiments.MethodRetrieved the related literatures from databases including PubMed, Web of Science, CNKI and WanFang, and after reading the literatures, different methods were sorted out, analyzed and summarized.ResultsThe mouse models commonly used in colorectal cancer research include the cell-derived xenograft (CDX), patient-derived xenograft (PDX), chemical reagent-induced tumor in situ, transgenic mice (ApcMin/+ mice), tumor cells derived from mice themselves were inoculated to the normal mice, and models of colorectal metastatic tumors (including liver, lung, abdomen and bone metastases, etc.). The CDX model cost shorter time to establish, and the PDX model restored the authentic phenotype of the tumor in patients, but the tumor were both colonized under the skin of nude mice, which lacked authenticity tumor microenvironment. The colorectal cancer in mice induced by chemical reagents and genetically engineered mice imitated the development of colorectal tumor in the situ intestine of mouse, but both of them were time-consuming. The model established by the tumor of mouse own was convenient for basic immune research of colorectal cancer, but the disadvantage was the unreal tumor microenvironment. The colorectal cancer metastasis model was an essential model for the study of the mechanism and treatment in metastasis colorectal tumor, but its establishment required higher operating skills and required the image examination to determine the whether the metastasis tumor was successfully generated or not.ConclusionsDifferent mouse models of colorectal cancer have different emphases, advantages and disadvantages. Researchers need to make accurate selection according to the research purpose and design needs.

    Release date:2021-06-24 04:18 Export PDF Favorites Scan
  • Fluoxetine pre-treatment exacerbates bleeding in a mouse model of intracerebral hemorrhage

    Objective To determine whether fluoxetine, a commonly used selective serotonin reuptake inhibitors (SSRIs), could exacerbate bleeding in a intracerebral hemorrhage (ICH) mouse model. Methods Forty two 12-14 month old female specific pathogen free C57BL/6 mice were selected. Mice were randomly divided into fluoxetine group (fluoxetine pre-treatment) and control group, with 21 mice in each group. After treated with fluoxetine for 7 days, ICH was induced by injecting collagenase Ⅶ-S into the right striatum of middle-aged female mice. Effects of fluoxetine on exacerbating bleeding were evaluated by a combination of histologic, molecular, cellular, and behavioral assessments. Results On the third day after ICH, the hemorrhage volumes of the control group and fluoxetine group were (4.59±1.80) mm3 and (6.09±1.08) mm3, respectively. In middle-aged female mice subjected to collagenase-induced ICH, fluoxetine pre-treatment significantly exacerbated neurological deficit, cerebral hemorrhage volume, myelin damage, hemoglobin and iron deposition, neuronal degeneration, and brain edema (P<0.05). Although there was no significant difference in tail bleeding time between the two groups, fluoxetine pre-treatment might increase tail bleeding time [(276.73±211.06) vs. (438.00±236.79) s; t=−1.686, P=0.055]. Conclusions The use of fluoxetine and more generally of SSRIs, which inhibits platelet aggregation, may exacerbate bleeding after ICH. Thus, patients with depression after ICH may avoid concomitant use of such drugs when choosing an antidepressant.

    Release date:2022-04-25 03:47 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content